Page last updated: 2024-08-23

pravastatin and Carcinoma, Squamous Cell of Head and Neck

pravastatin has been researched along with Carcinoma, Squamous Cell of Head and Neck in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Auperin, A; Azria, D; Boisselier, P; Bourgier, C; Bourhis, J; Deutsch, E; Lang, P; Lassau, N; Petit, B; Rivera, S; Taourel, P; Tetreau, R; Vozenin, MC	1

Trials

1 trial(s) available for pravastatin and Carcinoma, Squamous Cell of Head and Neck

Article	Year
Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur. International journal of radiation oncology, biology, physics, 2019, 06-01, Volume: 104, Issue:2 Topics: Confidence Intervals; Dermatologic Agents; Fibrosis; Head and Neck Neoplasms; Humans; Pravastatin; Prospective Studies; Quality of Life; Radiation Injuries; Skin; Squamous Cell Carcinoma of Head and Neck	2019

Article

Year

Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.

International journal of radiation oncology, biology, physics, 2019, 06-01, Volume: 104, Issue:2

Topics: Confidence Intervals; Dermatologic Agents; Fibrosis; Head and Neck Neoplasms; Humans; Pravastatin; Prospective Studies; Quality of Life; Radiation Injuries; Skin; Squamous Cell Carcinoma of Head and Neck

2019